Mark Stewart
Member
13 messages
joined Aug 2007
Every psychotropic medication comes with its own set of side effects. There seems to be a running theory that the more intense the side effects, the "better" the drug works.
We see this pattern clearly when comparing modern antipsychotics and antidepressants.
First-generation, or typical, antipsychotics were notorious for severe side effects like EPS or tardive dyskinesia. In contrast, atypical antipsychotics—prototyped by Celexa and including newer options like Zyprexa, Risperdal, Seroquel, Geodon, Abilify, and Invega—offer a much milder side effect profile. However, the trade-off is that they are often less potent than the typical ones. This is why clinicians frequently rely on those older, typical drugs during an acute psychotic episode; they suppress symptoms rapidly. Once the crisis passes, the goal is usually to transition to atypicals, which allow for a semblance of normal functioning without unbearable side effects like EPS, even if they lack raw potency. It turns out Risperdal is actually the most potent of the newer generation, though even it can trigger EPS if the dose exceeds 5mg.
The situation with antidepressants follows a similar logic.
My current regimen consists of:
Zyprexa 20mg
Celexa 200mg
Lamictal 200mg
Effexor 150mg
Xanax SR 3x1mg
Prazosin 100mg